Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients - PubMed (original) (raw)
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients
P A Velilla et al. AIDS Res Hum Retroviruses. 2008 Jan.
Abstract
We evaluated the effect of low-dose IL-2 therapy (daily 1.2 MIU/m(2), subcutaneously) on the number and phenotype of regulatory T cells (T(regs)) and natural killer (NK) cells in HIV/HCV-coinfected patients taking antiretroviral therapy. The frequency and phenotype of circulating T(regs) (defined as CD3(+) CD4(+) CD25(high) or CD3(+) CD4(+) FOXP3(+)) and NK cells (CD3(-) CD16(+)/CD56(+)) were evaluated at baseline and after 12 weeks of treatment. The expression of CD25, CTLA-4, and granzymes A and B by CD4(+) FOXP3(+) cells, as well as the expression of KIR receptors (NKB1, CD158a, and NKAT2) on NK cells, was evaluated. Low doses of IL-2 resulted in the augmented frequency and absolute number of T(regs) in coinfected individuals. FOXP3 levels per cell as well as augmented CD25 and CTLA-4 expression by T(regs) suggested that IL-2 may lead to both expansion and activation of T(regs), although changes in the proportion of CD4(+) FOXP3(+) cells were not associated with changes in HCV viral load and CD4(+) cells between baseline and week 12. NK cell frequency also increased after IL-2 therapy. Interestingly, the pattern of expression of KIR receptors was changed by IL-2 treatment, since the frequency of NK cells expressing NKB1 augmented whereas the frequency of NK expressing CD158a and NKAT2 decreased.
Similar articles
- Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M, Napolitano M, Costantini S, Portella L, Esposito A, Capone F, Guerriero E, Trotta A, Zanotta S, Pucci L, Longo N, PerdonĂ S, Pignata S, Castello G, Scala S. Polimeno M, et al. BJU Int. 2013 Sep;112(5):686-96. doi: 10.1111/bju.12068. Epub 2013 Mar 15. BJU Int. 2013. PMID: 23495770 - Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L, Trehanpati N, Poonia S, Daigh L, Sarin SK, Masur H, Kottilil S. Barrett L, et al. J Viral Hepat. 2015 Mar;22(3):281-8. doi: 10.1111/jvh.12291. Epub 2014 Sep 1. J Viral Hepat. 2015. PMID: 25174689 - HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E, Azzoni L, Yin X, Liu Q, Joseph J, Mackiewicz A, Ross B, Lynn KM, Jacobson JM, Mounzer K, Kostman JR, Montaner LJ. Papasavvas E, et al. J Viral Hepat. 2017 Oct;24(10):865-876. doi: 10.1111/jvh.12714. Epub 2017 May 11. J Viral Hepat. 2017. PMID: 28419653 Free PMC article. - Therapy implications of the role of interleukin-2 in cancer.
Lissoni P. Lissoni P. Expert Rev Clin Immunol. 2017 May;13(5):491-498. doi: 10.1080/1744666X.2017.1245146. Epub 2016 Oct 26. Expert Rev Clin Immunol. 2017. PMID: 27782752 Review.
Cited by
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes.
Pham MN, von Herrath MG, Vela JL. Pham MN, et al. Front Immunol. 2016 Jan 11;6:651. doi: 10.3389/fimmu.2015.00651. eCollection 2015. Front Immunol. 2016. PMID: 26793191 Free PMC article. Review. - Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells.
Rios CM, Velilla PA, Rugeles MT. Rios CM, et al. Open Virol J. 2012;6:49-58. doi: 10.2174/1874357901206010049. Epub 2012 Apr 11. Open Virol J. 2012. PMID: 22582105 Free PMC article. - Innate immune natural killer cells and their role in HIV and SIV infection.
Bostik P, Takahashi Y, Mayne AE, Ansari AA. Bostik P, et al. HIV Ther. 2010 Jul 1;4(4):483-504. doi: 10.2217/HIV.10.28. HIV Ther. 2010. PMID: 20730028 Free PMC article. - Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.
Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC. Mealey RH, et al. Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19368787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials